Back to search
FDAFDA · Food and drugs·Recall number Z-1513-2013

ADVIA Centaur® iPTH ReadyPack Assay 500 Tests; REF 10492369, 10493615, 1049361. For in vitro diagnostic use in the quantitative determination of intact parathyroid hormone (iPTH).

Published June 12, 2013 · Recall initiated: May 14, 2013

Summary

FDA records medical device Class II recall Z-1513-2013, published June 12, 2013 and initiated May 14, 2013. Recalling firm: Siemens Healthcare Diagnostics, Inc; Status: Terminated; Reported quantity: 3302 Kits (500 test); Lot: Reagent Lot Numbers: 056301 and 56302 Kit Lot Number/Exp. Date: REF 10492369- 500 Tests 61639301 09 Nov 2011 REF 1 0493615 - 500 Tests 63607301 09 Nov 2011 68004301 09 Nov 2011 70229301 09 Nov 2011 74126301 09Nov2011 REF 10493616-500 Tests 62645302 09 Nov 2011 66612302 09 Nov 2011 74129302 09 Nov 2011. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

iPTH Assay- reagent and calibrator lots may have demonstrated higher than anticipated variability

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Siemens Healthcare Diagnostics, Inc
Distributor
Nationwide Distribution.
Lot
Reagent Lot Numbers: 056301 and 56302 Kit Lot Number/Exp. Date: REF 10492369- 500 Tests 61639301 09 Nov 2011 REF 1 0493615 - 500 Tests 63607301 09 Nov 2011 68004301 09 Nov 2011 70229301 09 Nov 2011 74126301 09Nov2011 REF 10493616-500 Tests 62645302 09 Nov 2011 66612302 09 Nov 2011 74129302 09 Nov 2011
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was ADVIA Centaur® iPTH ReadyPack Assay 500 Tests; REF 10492369, 10493615, 1049361. For in vitro diagnostic use in the quantitative determination of intact parathyroid hormone (iPTH). recalled?

Yes. FDA published recall Z-1513-2013 on June 12, 2013. Reported hazard: iPTH Assay- reagent and calibrator lots may have demonstrated higher than anticipated variability

What should I do if I have this product?

Voluntary: Firm initiated · Letter